lamivudine
Generic: lamivudine
Labeler: lupin pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
lamivudine
Generic Name
lamivudine
Labeler
lupin pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
lamivudine 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68180-602
Product ID
68180-602_0852eda3-c1d3-426d-b73d-c7f08dfd9584
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205217
Listing Expiration
2026-12-31
Marketing Start
2015-03-25
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68180602
Hyphenated Format
68180-602
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lamivudine (source: ndc)
Generic Name
lamivudine (source: ndc)
Application Number
ANDA205217 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 16 HOW SUPPLIED/STORAGE AND HANDLING Lamivudine Scored Tablets USP, 150 mg White to off white scored capsule shaped, film coated tablets, debossed on both tablet faces, such that, when broken in half "L" and "5" code is present on both halves of the tablet ("L" on one side and "5" on the opposite face of the tablet). Bottle of 60 tablets (NDC 68180-602-07) with child-resistant closure. Bottle of 100 tablets (NDC 68180-602-01) with child-resistant closure. Lamivudine Tablets USP, 300 mg Gray coloured capsule shaped, film coated tablets, debossed with "L" on one side and "6" on the other side. Bottle of 30 tablets (NDC 68180-603-06) with child-resistant closure. Recommended Storage: Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Lamivudine Tablets 150 mg Bottle of 60 Tablets 68180-602-07 Lamivudine Tablets 300 mg Bottle of 30 Tablets 68180-603-06 image-03 image-04
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0852eda3-c1d3-426d-b73d-c7f08dfd9584", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0368180603061", "0368180602071"], "unii": ["2T8Q726O95"], "rxcui": ["199147", "349491"], "spl_set_id": ["ff3b5265-f533-4332-a861-d8c9c1664ffd"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Lamivudine", "product_id": "68180-602_0852eda3-c1d3-426d-b73d-c7f08dfd9584", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "68180-602", "generic_name": "Lamivudine", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}], "application_number": "ANDA205217", "marketing_category": "ANDA", "marketing_start_date": "20150325", "listing_expiration_date": "20261231"}